Any diffuse thinners have a good experience with Minox and is foam or liquid preferred??? Minoxidil 2/26/2024
A user with diffuse thinning experienced no hair regrowth with finasteride or Avodart but slowed hair loss with Avodart. They are considering trying Minoxidil and are seeking advice on whether to use foam or liquid, and if combining it with other treatments could be beneficial, excluding micro-needling due to scalp irritation concerns.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity Finasteride + Monxidil Update pictures.
A user shared progress pictures after using finasteride and minoxidil for two years, showing significant hair improvement. The user started treatment at age 20 and reported no side effects.
community Dutasteride (.5mg) is some strong stuff!
User switched from finasteride and minoxidil to dutasteride, experienced side effects, then took dutasteride once a week with improved hair density. Another user had success with daily dutasteride, while one had no results from topical dutasteride.
community 5 months of Dutasteride, still loosing ground, has anyone had a similar situation and recovered?
OP switched from finasteride to dutasteride due to hair loss, but after 5 months, they are experiencing diffuse thinning and scalp issues. They are considering additional treatments like RU58841 and are using minoxidil, essential oils, and keto shampoo to manage symptoms.
community I've set a date where I'll give up treatment, want some other people's stories, I feel so hopeless.
A user is considering stopping hair loss treatments, including finasteride, dutasteride, and minoxidil, due to lack of progress after 16 months. They plan to continue until October and are seeking advice and experiences from others.
community Stop wasting your time with BS products
Effective treatments for hair loss include finasteride, dutasteride, RU58841, and minoxidil. Starting treatment early is important, and users discuss different brands, forms, and side effects.
Related Research
6 / 6 results
research Current understanding and treatment of sex hormone-related hair diseases
This review examines the effects of sex hormones on hair growth and the pathogenesis of related hair disorders, highlighting current management benefits and controversies but reporting no new results.
research Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to the Hair Follicle
This review examines new formulations for delivering 5-α-reductase inhibitors to improve targeted drug delivery in androgenetic alopecia, but reports no new clinical results.
research The shifting preferences of patients and physicians in nonsurgical hair loss treatment
This study analyzed trends in consumer and physician interest in nonsurgical hair loss therapies, finding that internet searches for treatments like minoxidil and low-level laser therapy increased over time, influenced by regulations and social media.
research Lipid nanocarriers as innovative strategies for hair regrowth
This review discusses current treatment strategies for alopecia and highlights the potential of lipid-based nanoparticles to improve drug delivery to the scalp and hair follicles, noting their ability to enhance skin penetration and drug stability while outlining associated challenges and the need for further research.
research Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery
This study found that dutasteride-loaded nanostructured lipid carriers coated with a stearic acid-chitosan oligomer are stable, less cytotoxic, and suitable for topical delivery to promote hair growth.
research Enhanced ex vivo skin retention of bicalutamide using a nano-in-micro composite: Drug-loaded lipid vesicles in a dissolving microarray patch
This study developed and tested Bicalutamide-loaded lipid vesicles in dissolving microarray patches for topical application, finding that they effectively deliver Bicalutamide through murine skin while maintaining a favorable safety profile, suggesting potential to improve treatments for androgenetic alopecia.